MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 04-25-2026
EDAP TMS S.A. EV/EBITDA Ratio 2011-2026 | EDAP
Annual EV/EBITDA Ratio EDAP TMS S.A.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 730 | 122 | 23.3 | 209 | -132 | 49.9 | 52.8 | -75.5 | -37.5 | -42.5 | -35 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 730 | -132 | 78.6 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B |  USA |
 |
AdaptHealth Corp.
AHCO
|
11 | $ 13.02 | 1.72 % | $ 1.76 B | USA |
 |
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | USA |
 |
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.62 | -2.1 % | $ 38.6 M | USA |
 |
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
-9.73 | $ 11.1 | -5.77 % | $ 314 M | USA |
 |
Globus Medical
GMED
|
27.6 | $ 93.97 | -0.96 % | $ 12.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
-0.0925 | $ 2.13 | -1.16 % | $ 1.29 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
26.4 | $ 26.2 | -0.72 % | $ 221 M | USA |
 |
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | USA |
 |
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B |  Israel |
 |
LivaNova PLC
LIVN
|
215 | $ 63.24 | -1.5 % | $ 3.45 B |  Britain |
 |
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | USA |
 |
LENSAR
LNSR
|
-1.48 | $ 5.15 | 1.18 % | $ 61.6 M | USA |
 |
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M |  Canada |
 |
Pulmonx Corporation
LUNG
|
-22.5 | $ 1.26 | -0.39 % | $ 51.3 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-165 | $ 15.88 | -1.91 % | $ 373 M | USA |
 |
Butterfly Network
BFLY
|
-3.9 | $ 5.58 | 4.59 % | $ 1.18 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | USA |
 |
Insulet Corporation
PODD
|
95.3 | $ 187.73 | -0.97 % | $ 13.2 B | USA |
 |
Delcath Systems
DCTH
|
-1.69 | $ 10.82 | -0.18 % | $ 388 M | USA |
 |
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.08 | 1.89 % | $ 18.3 M | USA |
 |
CONMED Corporation
CNMD
|
40.2 | $ 38.44 | 0.16 % | $ 1.19 B | USA |
 |
Inspire Medical Systems
INSP
|
-152 | $ 54.68 | -2.83 % | $ 1.61 B | USA |
 |
Integer Holdings Corporation
ITGR
|
18.2 | $ 84.01 | -2.32 % | $ 2.92 B | USA |
 |
PAVmed
PAVM
|
-1.57 | $ 8.32 | -7.56 % | $ 5.58 M | USA |
 |
Sintx Technologies
SINT
|
0.974 | $ 2.41 | -2.43 % | $ 6.68 M | USA |
 |
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
39.2 | $ 84.41 | 0.19 % | $ 49.4 B | USA |
 |
Stryker Corporation
SYK
|
30 | $ 329.17 | 0.51 % | $ 126 B | USA |
 |
MiMedx Group
MDXG
|
-669 | $ 3.36 | -2.19 % | $ 497 M | USA |
 |
Tactile Systems Technology
TCMD
|
241 | $ 24.4 | -2.67 % | $ 558 M | USA |
 |
Nevro Corp.
NVRO
|
-23.6 | - | - | $ 217 M | USA |